Open AccessUsing highly active antiretroviral therapy to decrease perioperative HIV-1 transmission risk
Author(s) -
Adam M. Spivak,
Robert F. Siliciano
Publication year - 2010
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32832f3155
Subject(s) - raltegravir , integrase inhibitor , efavirenz , maraviroc , regimen , viral load , virology , dolutegravir , emtricitabine , integrase , population , medicine , perioperative , biology , immunology , antiretroviral therapy , virus , human immunodeficiency virus (hiv) , surgery , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom